R-5780-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-5780-01, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors [Phase 1]